1. Combination treatment of atezolizumab and bevacizumab was shown to significantly increase overall survival and progression-free survival outcomes in patients ...
1. Combination treatment of atezolizumab and bevacizumab was shown to significantly increase overall survival and progression-free survival outcomes in patients ...
1. In this prospective propensity score (PS)-matched cohort study, lipophilic statins were found to significantly reduce incidence and mortality of ...
1. When combined with hepatic artery ligation, the current treatment for hepatocellular carcinoma (HCC), tirapazimine (TPZ) was found to ...
1. This study established a simple, graphically-based prognostic nomogram for overall and progression-free survival in patients with non-metastatic hepatocellular carcinoma ...
1. In patients with chronic liver disease, magnetic resonance (MR) imaging was more sensitive than computed tomography (CT) for the ...
1. In a phase III trial of over 700 patients with hepatocellular carcinoma (HCC), there was no significant difference in ...
In this section, we highlight the key high-impact studies, updates, and analyses published in medicine during the past week. Effect of ...
1. Compared to placebo, treatment with everolimus did not improve survival in patients with advanced hepatocellular carcinoma (HCC) who had ...
1. This systematic review identified very-low strength evidence pertaining to the benefits of screening for hepatocellular carcinoma (HCC) among patients ...
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.